Satisfaction with care: An independent outcome measure in surgical oncology

被引:49
作者
Avery, Kerry N. L.
Metcalfe, Chris
Nicklin, Joanna
Barham, C. Paul
Alderson, Derek
Donovan, Jenny L.
Blazeby, Jane M.
机构
[1] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England
[2] Univ Bristol, Bristol Royal Infirm, Div Head & Neck Surg, Bristol BS2 8HW, Avon, England
[3] Univ Bristol, Bristol Royal Infirm, Clin Sci S Bristol, Bristol BS2 8HW, Avon, England
基金
英国医学研究理事会;
关键词
gastrointestinal neoplasms; outcome assessment; patient satisfaction; quality of life;
D O I
10.1245/ASO.2006.08.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Backgrond: Outcomes for treatment for upper gastrointestinal cancer traditionally include procedure-related morbidity and mortality and long-term survival. Patient-reported outcomes, such as quality of life (QOL) and satisfaction measures, add to standard end points, but associations between these factors are not fully understood. This study examined how patient satisfaction related to surgical morbidity, treatment type, and QOL outcomes after inpatient treatment for upper gastrointestinal cancer. Methods: Consecutive patients who had completed treatment in one unit were invited to participate in this study and complete the European Organization for Research and Treatment of Cancer QLQ-PATSAT32 and QLQ-C30 questionnaires within 2 months of discharge. Regression analyses examined relationships between satisfaction and surgical morbidity (major complications and type of treatment) and between satisfaction and QOL variables, adjusting for age and sex. Results: During the study, 181 patients were treated, 162 were eligible, and 139 returned both questionnaires (response rate, 86%). Of the study sample, the treatment outcome was potential cure in 105 (67 esophagectomy and 38 D2 gastrectomy), and 34 received palliative treatment. Thirty-seven patients (27%) had major complications. Patients who received palliative treatment reported satisfaction and QOL scores similar to those of patients who received curative treatment. However, patients who experienced major morbidity reported significantly worse QOL than those without morbidity (P < .01). Satisfaction scores were the same in patients with or without complications. There were no associations between satisfaction and QOL scores (r < .34). Conclusions: Patient satisfaction with hospital care is independent of morbidity, treatment type, and QOL outcomes. It may be used to feed back information to providers of health care to improve patients' experiences of treatment.
引用
收藏
页码:817 / 822
页数:6
相关论文
共 23 条
[1]
THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]
[Anonymous], 1996, J Clin Oncol, V14, P671
[3]
BLANCHARD CG, 1990, CANCER, V65, P186, DOI 10.1002/1097-0142(19900101)65:1<186::AID-CNCR2820650136>3.0.CO
[4]
2-4
[5]
Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma [J].
Blazeby, JM ;
Sanford, E ;
Falk, SJ ;
Alderson, D ;
Donovan, JL .
CANCER, 2005, 103 (09) :1791-1799
[6]
Feasibility of quality of life assessment in patients with upper gastrointestinal tract cancer [J].
Blazeby, JM ;
Nicklin, J ;
Brookes, ST ;
Winstone, K ;
Alderson, D .
BRITISH JOURNAL OF CANCER, 2003, 89 (03) :497-501
[7]
Blazeby JM, 2000, CANCER, V88, P1781
[8]
Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial [J].
Borras, JM ;
Sanchez-Hernandez, A ;
Navarro, M ;
Martinez, M ;
Mendez, E ;
Ponton, JLL ;
Espinas, JA ;
Germa, JR .
BRITISH MEDICAL JOURNAL, 2001, 322 (7290) :826-828A
[9]
An international prospective study of the EORTC cancer in-patient satisfaction with care measure (EORTC IN-PATSAT32) [J].
Brédart, A ;
Bottomley, A ;
Blazeby, JM ;
Conroy, T ;
Coens, C ;
D'Haese, S ;
Chie, WC ;
Hammerlid, E ;
Arraras, JI ;
Efficace, F ;
Rodary, C ;
Schraub, S ;
Costantini, M ;
Costantini, A ;
Joly, F ;
Sezer, O ;
Razavi, D ;
Mehlitz, M ;
Bielska-Lasota, M ;
Aaronson, NK .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (14) :2120-2131
[10]
Brédart A, 2005, CURR OPIN ONCOL, V17, P351